Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Egypt / NCT07768982
Starting soon Observational

Clinical Characteristics and Prognostic Factors in Patients With Meningitis at Sohag Governorate.

NCT07768982 · tracked via the Priya Life Science Egypt tracker
Sponsor
Sohag University
Phase
Observational
Started
2026-08-15
Last updated
2026-08-17

Condition(s) studied

Meningitis

Study summary

analyze the clinical characteristics and prognostic factors in patients with meningitis at Sohag Governorate .This is an ambidirectional (retrospective and prospective), hospital-based observational study. The study involves a retrospective review of patient records over the past 3 years, combined with a prospective recruitment of new patients for one year from the initiation of the study

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * All patients diagnosed with meningitis admitted to Sohag Fever Hospital during the study period. * Patients of all age groups and both sexes. * Patients with confirmed diagnosis based on clinical features and CSF analysis. Exclusion Criteria: * Patients with incomplete medical records. * Patients with uncertain diagnosis of meningitis. * Patients discharged against medical advice before completion of evaluation.

Primary outcome measure(s)

  • All-cause in-hospital mortality — From hospital admission until hospital discharge, up to 30 days.
    Death from any cause occurring during hospitalization, reported as the number and percentage of participants who died during hospital admission.

Trial sites (1)

FacilityCityRegionStatus
Sohag Fever Hospital Sohag Egypt

More Sohag University trials in Egypt

Colitis Patterns in Patients With Lower GI Symptoms Starting soon
Zadek Osteotomy for Treatment of Haglund's Syndrome Recruiting
Effects of Dexmedetomidine Combined With Lidocaine Topical Administration on Cough Reflex During Extubation in Thyroidectomy Patient. Active, not recruiting
Toxoplasma Gondii Seroprevalence Among Children With Some Neuropsychiatric Disorders Starting soon
Accuracy of Transabdominal Ultrasound in Predicting Intraperitoneal Adhesions Prior to Laparoscopy Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07768982 on ClinicalTrials.gov ↗ ← All trials in Egypt